Who invested in Andson Biotech

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Y Combinator: W22

Funding summaryUpdated 26 Oct 2026

$8.3Mraised across 2 rounds since 2024, from 2 sources

$3.6MSeed$4.7MVenture

Latest round: Venture, $4.7MOct 2025
Step-upi: 1.3×
Investors: 2

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2025

$3.6MSeed$4.7MVenture

First round: Seed, $3.6M
Biggest round: $4.7M
Between rounds: 19 months

The rounds

Oct 2025
Venture$4.7M2 returning
- Y Combinator
- Unpopular Ventures
Source recordedSEC filing: $4.7M sold, first sale Oct 2025
Mar 2024
Seed$3.6M2 new
- Y Combinator
- Unpopular Ventures
Source recordedSEC filing: $3.6M sold, first sale Mar 2024

Founders and team

From Andson Biotech's own website: 4 on the team.

Jim FilippiniPresident & Chief Commercial Officer
Rob GrierVice President of Operations
Glenn EpsteinBoard Member
Tom O’BrienExecutive Chairman

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2024Venture2025

Y Combinator

Unpopular Ventures

Everyone who backed them

Y CombinatorAccelerator2rounds

Unpopular VenturesVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Andson Biotech as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.